Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group.
Related posts
-
Digging in: Major Route 53 overhaul = angst through 2026
Here’s the lowdown on what Route 53 work between Lake-Cook Road and Route 62 means for... -
Community colleges renew push for four-year degrees, but universities push back
Harper College and other community colleges are lobbying legislators for the right to offer four-year bachelor’s... -
After-school programs continue push for state aid
SPRINGFIELD -- Advocates for after-school programs that provide tutoring, recreation and other services made their case...